常见的生物标志物和炎症性肠病和乳腺癌的发病:门德尔随机化和多组学研究

Daqing Zhang1, Yongjun Guan1, Haitao Tang2

  • 1Department of General Surgery, Beijing Friendship Hospital, Capital Medical University,State Key Lab of Digestive Health,National Clinical Research Center for Digestive Diseases, Beijing, People's Republic of China.

PubMed
概括

炎症性肠病 (IBD) 增加了乳腺癌的风险. 该研究确定THBS3作为一个共享的生物标志物,可能会推动癌症的进展,并为改善患者的治疗结果提供治疗目标.